A Rare Case of Adrenal Cysts Associated With Bilateral Incidentalomas and Diffuse Hyperplasia of the Zona Glomerulosa.

SGLT2 inhibitor adrenal incidentaloma aldosterone diffuse adrenocortical hyperplasia endothelial cyst renin

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Feb 2021
Historique:
received: 15 09 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 1 1 2021
Statut: epublish

Résumé

Characterization of adrenocortical disorders is challenging because of varying origins, laterality, the presence or absence of hormone production, and unclarity about the benign or malignant nature of the lesion. Histopathological examination in conjunction with immunohistochemistry is generally considered mandatory in this characterization. We report a rare case of bilateral adrenocortical adenomas associated with unilateral adrenal endothelial cysts in a 65-year-old woman whose condition was not diagnosed before surgery. Detailed histological examination of the resected adrenal glands revealed hyperplasia in the zona glomerulosa. Despite hyperplasia, the patient had normal serum aldosterone levels and renin activity without clinical evidence of hypertension. The patient was treated with a sodium-glucose cotransporter protein 2 (SGLT2) inhibitor. This may have stimulated the renin-angiotensin-aldosterone system. To the best of our knowledge, this is the first case in which both relatively large bilateral adrenocortical adenomas and unilateral adrenal endothelial cysts were detected. This case also highlights the complexity and difficulty of preoperative diagnosis. Furthermore, this case reports the first detailed histopathological examination of adrenal lesions with SGLT2 treatment and the possibility of SGLT2 inhibitor treatment resulting in histological hyperplasia in the zona glomerulosa; however, it is difficult to prove a causative relationship between SGLT2 inhibitors and hyperplasia of the zona glomerulosa based on the data of this case. It can be confirmed only under limited conditions; therefore, further studies on adrenal gland histology employing SGLT2 inhibition are warranted.

Identifiants

pubmed: 33381672
doi: 10.1210/jendso/bvaa184
pii: bvaa184
pmc: PMC7751009
doi:

Types de publication

Case Reports

Langues

eng

Pagination

bvaa184

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Am J Cardiol. 2019 Dec 15;124 Suppl 1:S45-S52
pubmed: 31741440
World J Surg. 2006 Oct;30(10):1817-20
pubmed: 16983481
Cancer. 2004 Oct 1;101(7):1537-44
pubmed: 15378490
Lancet Diabetes Endocrinol. 2020 Sep;8(9):773-781
pubmed: 32711725
Ann Surg. 2020 Jun 11;:
pubmed: 32541223
Cardiovasc Diabetol. 2019 Apr 5;18(1):46
pubmed: 30953516
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1182-1192
pubmed: 28388725
Am J Med. 2017 Nov;130(11):e479-e483
pubmed: 28756269
Arch Pathol Lab Med. 2006 Nov;130(11):1722-4
pubmed: 17076539
J Histochem Cytochem. 2011 May;59(5):557-64
pubmed: 21411711
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
Hum Pathol. 2018 Dec;82:95-102
pubmed: 30041023
J Visc Surg. 2014 Oct;151(5):355-64
pubmed: 25127879
J Clin Med Res. 2020 Mar;12(3):165-171
pubmed: 32231752
Intern Med. 2009;48(4):235-40
pubmed: 19218775
Int J Mol Sci. 2019 Feb 01;20(3):
pubmed: 30717173
J Clin Endocrinol Metab. 2013 Apr;98(4):1567-74
pubmed: 23443813
N Engl J Med. 2007 Feb 8;356(6):601-10
pubmed: 17287480
J Clin Endocrinol Metab. 2010 Sep;95(9):4106-13
pubmed: 20823463
J Clin Endocrinol Metab. 2000 Feb;85(2):637-44
pubmed: 10690869
Pathol Res Pract. 2011 Mar 15;207(3):192-6
pubmed: 20846791
AJR Am J Roentgenol. 2010 Jun;194(6):1450-60
pubmed: 20489083
Int Braz J Urol. 2014 Sep-Oct;40(5):656-65
pubmed: 25498277
J Steroid Biochem Mol Biol. 2019 Jul;191:105361
pubmed: 30974191
Endocr J. 2016 Sep 30;63(9):765-784
pubmed: 27350721
Diseases. 2020 May 11;8(2):
pubmed: 32403420
Endocr J. 2018 Aug 27;65(8):859-867
pubmed: 29806620

Auteurs

Naru Babaya (N)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Yuki Okuda (Y)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Shinsuke Noso (S)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Yoshihisa Hiromine (Y)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Yasunori Taketomo (Y)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Fumimaru Niwano (F)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Kazuki Ueda (K)

Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.

Yumiko Tanaka (Y)

Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.

Yuto Yamazaki (Y)

Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.

Hironobu Sasano (H)

Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.

Yumiko Kawabata (Y)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Yasuhiro Ohno (Y)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Hiroshi Ikegami (H)

Department of Endocrinology, Metabolism and Diabetes, Kindai University Faculty of Medicine, Osaka, Japan.

Classifications MeSH